TABLE 3.
Comparison of studies evaluating short chain fatty acids (SCFA) effects on murine amyloid models.
| Study | Treatment | Mouse model | Microbiome | Mouse age during treatment | Effect on amyloid burden |
| Fernando et al., 2020 | NaB was added to chow pellets at a concentration of either 40 mg/kg or 120 mg/kg where mice would receive either 5 mg/kg/day, or 15 mg/kg/day | 5xFAD with APOE3 | Conventional | From 8 weeks to 20 weeks | Reduced |
| Jiang et al., 2021 | 0.2 g/kg daily intraperitoneal injection of NaB (0.1 ml/10 g) * | 5xFAD | SPF | From 8 weeks to 10 weeks | Reduced |
| Colombo et al., 2021 | 67.5 mM sodium acetate, 25 mM sodium propionate, 40 mM sodium butyrate, pH 6.8 in drinking water | APPPS1 | SPF | From 8 weeks to 13 weeks | Increased |
| Zajac et al., 2022 | 67.5 mM sodium acetate, 25 mM sodium propionate, 40 mM sodium butyrate, pH 6.8 in drinking water * | APP/PS1 | Conventional | From 20 weeks to 40 weeks | No change |
*SCFA treatment was compared to saline control.